Tardugno Michael H 4

What Happened

• Michael H. Tardugno, Executive Chairman and Director of Imunon, Inc., was granted 4,629 shares on 2026-06-18 at an implicit price of $1.82 per share, totaling roughly $8,425. This transaction is recorded on the Form 4 as an award/grant (code A) and represents stock issued in lieu of cash compensation.

Key Details

• Transaction date: 2026-06-18
• Price per share: $1.82; Total value: ~$8,425
• Transaction type: Award/Grant (Form 4 code A)
• Shares owned after transaction: Not specified in the provided filing
• Footnote: F1 — "Stock granted in lieu of cash for base salary"
• Filing date: 2026-06-23 (filed 5 days after the transaction; Form 4s are generally required within two business days, so this appears to be a late filing)

Context

• This was a compensation award, not an open-market purchase or sale, and is often routine (stock issued instead of cash salary). Such grants are part of executive pay and do not, by themselves, indicate a buy/sell signal for investors. The late filing reduces near-term transparency but does not change the nature of the transaction.